Endocrinology Video Recap—December 16, 2025
This biweekly endocrinology video recap covers major regulatory decisions,…
Lucid Diligence Brief: Prolynx $70m Series A for long-acting obesity candidates
Lucid Diligence Brief: Prolynx $70m Series A for long-acting obesity……
Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal
Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal Professional audiences…
Obesity Today—December 9, 2025
This week’s obesity update spotlights key developments, regulatory milestones,…
Public Health Today—5 December, 2025
This Public Health weekly update highlights new evidence shaping behavioural,…
Obesity Today—December 2, 2025
This week’s obesity update spotlights key developments, regulatory milestones,…
Obesity Today—November 25, 2025
This week’s obesity update brings you the latest clinical advancements,…
Obesity Today—November 18, 2025
Weekly Obesity update featuring major pipeline moves, regulatory and access…
Lucid Diligence Brief: ABL Bio and Eli Lilly Grabody-B license deal
Lucid Diligence Brief: ABL Bio and Eli Lilly Grabody-B license deal…
AI in Healthcare and Digital Health Today—November 10, 2025
This week’s AI in Healthcare and Digital Health brief distills AI-driven…
AHA 2025 Preview: Key Cardiovascular Highlights to Watch
AHA 2025 at a glance Get ready for AHA 2025 with LucidQuest’s concise preview.…
Endocrinology Today — October 28, 2025
Endocrinology news this week covers major developments, updates, launches and…